Correction: Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy.

Autor: Abouhajar, Alaa, Alcock, Lisa, Bigirumurame, Theophile, Bradley, Penny, Brown, Laura, Campbell, Ian, Del Din, Silvia, Faitg, Julie, Falkous, Gavin, Gorman, Grainne S., Lakey, Rachel, McFarland, Robert, Newman, Jane, Rochester, Lynn, Ryan, Vicky, Smith, Hesther, Steel, Alison, Stefanetti, Renae J., Su, Huizhong, Taylor, Robert W.
Předmět:
Zdroj: Trials; 10/5/2022, Vol. 23 Issue 1, p1-1, 1p
Abstrakt: Originally published name: Sylvia Del Din Corrected name: Silvia Del Din The original article has been corrected. Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy. [Extracted from the article]
Databáze: Complementary Index
Nepřihlášeným uživatelům se plný text nezobrazuje